Fresh Rounds

Navega Therapeutics, Inc. funding

Navega Therapeutics, Inc., a biotechnology company based in San Diego, CA, filed a Form D with the SEC on January 30, 2026 and reported $1.3M raised of a $2.5M offering.

Amount raised$1.3M
Offering size$2.5M
Filed with the SECJanuary 30, 2026
First saleJanuary 2, 2026
IndustryBiotechnology
SecuritiesSecurity to be acquired on exercise
LocationSan Diego, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far8
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in California